Related Experiment Video
Updated: May 30, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
A prospective series of patients with hyperglycaemia-associated movement disorders
Amin Cervantes-Arriaga1, Georgina Arrambide, Mayela Rodríguez-Violante
1Clinical Neurodegenerative Disease Research Unit, National Institute of Neurology and Neurosurgery, Insurgentes Sur 3877 Tlalpan, Mexico City 14269, Mexico. acervantes@innn.edu.mx
Abstract:
Hyperglycaemia-associated movement disorders (MD) usually appear in older patients with diabetes and are related to acute peaks in blood glucose levels. This study aimed to describe the clinical features of a prospective series of patients with movement disorders associated with hyperglycaemia. We present a series of seven women and three men diagnosed with hyperglycaemia-associated MD who were followed for at least 1 year. Clinical evolution, treatment and neuroimaging findings are presented. Mean (± standard deviation [SD]) of the age at onset was 67.7 ± 11.7 years and mean (± SD) fasting glucose was 359.7 ± 162.5mg/dL. Putaminal hyperintensity on T1-weighted MRI was present in almost all instances. Two patients had pontine lesions compatible with osmotic myelinolysis. At follow-up, eight patients had a complete remission. We conclude that the clinical profile of patients in our series is similar to those reported in the literature. No clinical or metabolic features were found to be correlated with remission. Similarities with osmotic myelinolysis syndromes are discussed as an alternative aetiological hypothesis.
Related Concept Videos
Hyperglycemia
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type I Diabetes III: Clinical Manifestations
Type II Diabetes II: Pathophysiology
Hyperosmolar Hyperglycemic State
Type I Diabetes I: Introduction
